| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid-d8 | 69254-37-1 | sc-205209 sc-205209A | 1 mg 5 mg | $233.00 $801.00 | 5 | |
Arachidonic Acid-d8 serves as a potent ras gap, characterized by its ability to modulate GTPase activity through specific interactions with the ras protein. Its deuterated structure enhances stability and alters reaction kinetics, facilitating precise control over signaling pathways. The compound's unique hydrophobic regions promote effective membrane integration, influencing its interaction dynamics and enhancing the specificity of downstream effector recruitment. This specificity is crucial for regulating cellular responses. | ||||||
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $60.00 $80.00 | 15 | |
Farnesyl thiosalicylic acid is a small molecule Ras Gap inhibitor that interferes with Ras membrane localization by disrupting farnesylation, a post-translational modification necessary for Ras activation. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
Tipifarnib is another farnesyltransferase inhibitor that prevents the farnesylation of Ras, thereby inhibiting its activity. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Lonafarnib is a farnesyltransferase inhibitor. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $215.00 $622.00 | 5 | |
Manumycin A is a natural compound that inhibits farnesyltransferase and, consequently, Ras activation. It has been explored as a potential anti-cancer agent. | ||||||
Linsitinib | 867160-71-2 | sc-396762 sc-396762A | 5 mg 10 mg | $143.00 $260.00 | 1 | |
While primarily known as an insulin-like growth factor 1 receptor (IGF-1R) inhibitor, Linsitinib can indirectly affect Ras signaling by targeting upstream pathways involved in Ras activation. | ||||||